Lv6
2160 积分 2024-04-09 加入
Machine Learning for Predicting the Drug-to-Antibody Ratio (DAR) in the Synthesis of Antibody–Drug Conjugates (ADCs)
15天前
已完结
Artificial intelligence in antibody–drug conjugate development
15天前
已完结
Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies
1个月前
已完结
Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study
1个月前
已完结
A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer
1个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
1个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
3个月前
已完结
Kinetic Studies of the Partial Reduction and Conjugation Reactions in an Antibody-Drug Conjugate (ADC) Synthesis
4个月前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
4个月前
已完结
Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
8个月前
已完结
皖公网安备34019202002308
